Pressure Opening With Electrical Impedance Tomography
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Apr 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to measure lung function in patients with Acute Respiratory Distress Syndrome (ARDS) or Acute Lung Injury. The researchers want to see if using a tool called electrical impedance tomography (EIT) can help doctors better understand how air moves in different parts of the lungs. This information may improve how mechanical ventilation is set up for patients, potentially leading to better care.
To participate in the trial, patients must be at least 18 years old and have a specific level of oxygen in their blood. They must also be on a type of breathing support that controls either volume or pressure. Participants will be sedated and lying on their back during the study. It’s important to know that certain conditions, like severe lung disease or unstable blood pressure, may prevent someone from joining the trial. If eligible, participants can expect to undergo a procedure that involves low-flow air being given to their lungs while both the ventilator and EIT monitor are used to gather valuable information about their lung function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥18 years old).
- • Patients with PaO2/FiO2 ratio \<300 mmHg.
- • Volume- or pressure-controlled ventilation.
- • Sedated, with or without infusion of neuromuscular blockage.
- • Patients in supine position
- Exclusion Criteria:
- • Pneumothorax and bronchopleural fistula.
- • Severe hemodynamic instability (\>30 % increase in vasopressors in the last 6 hours or norepinephrine \> 0.5 µg/kg/min).
- • PaO2/FiO2 ratio \< 80 mmHg.
- • Severe or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD criteria (stage III: FEV1 30-50% predicted; stage IV: FEV1 \< 30 % predicted).
- • Known or highly suspected elevated intracranial pressure (\>18 mmHg).
- • Impossibility to correctly position the EIT belt (e.g., burns chest drainage, etc.).
- • Contraindications to EIT (e.g., implantable cardiac defibrillator, pacemaker, instable spinal lesions, etc.).
- • Clinical judgement of the attending physician.
- • Pregnant or breastfeeding woman
- • Patient under guardianship, curators or safeguard of justice
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported